Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hooper

Showing results (261-270 of 470) with videos related to

Pageof 47
Sort By:
Proceedings of the Australian Association of Neurologists|January 1, 1975
The bioavailability of carbamazepineL M Cotter, G Smith, W D Hooper, et al.
Clinical and Experimental Neurology|January 1, 1988
Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepineR G Dickinson, W D Hooper, S C Pendlebury, et al.
Australian and New Zealand Journal of Medicine|August 1, 1973
The effect of certain drugs on the plasma protein binding of phenytoinW D Hooper, J M Sutherland, F Bochner, et al.
Genomics|June 14, 2000
Cloning of the cDNA and localization of the gene encoding human NRBP, a ubiquitously expressed, multidomain putative adapter proteinJ D Hooper, E Baker, S M Ogbourne, et al.
British Journal of Clinical Pharmacology|July 1, 1989
The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoinR G Dickinson, W D Hooper, B Wood, et al.
Journal of the Autonomic Nervous System|December 1, 1994
The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in ratsG Eisenhofer, W Pecorella, K Pacak, et al.
Clinical Pharmacology and Therapeutics|September 1, 1973
The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoinF Bochner, W D Hooper, J M Sutherland, et al.
ANZ Journal of Surgery|January 24, 2023
Malignant polyps in the COVID-19 era: a population-based analysisAndrew P Zammit, Ian Brown, John D Hooper, et al.
Therapeutic Drug Monitoring|January 1, 1985
Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studiesW D Hooper, A R King, M Patterson, et al.
Annals of Coloproctology|March 25, 2024
Estimation of risk posed by malignant polyps amongst colorectal surgeons in Australia and New ZealandAndrew P Zammit, Ian Brown, John D Hooper, et al.
Pageof 47

Showing results (261-270 of 470) with videos related to

Sort By:
Pageof 47
Proceedings of the Australian Association of Neurologists|January 1, 1975
The bioavailability of carbamazepineL M Cotter, G Smith, W D Hooper, et al.
Clinical and Experimental Neurology|January 1, 1988
Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepineR G Dickinson, W D Hooper, S C Pendlebury, et al.
Australian and New Zealand Journal of Medicine|August 1, 1973
The effect of certain drugs on the plasma protein binding of phenytoinW D Hooper, J M Sutherland, F Bochner, et al.
Genomics|June 14, 2000
Cloning of the cDNA and localization of the gene encoding human NRBP, a ubiquitously expressed, multidomain putative adapter proteinJ D Hooper, E Baker, S M Ogbourne, et al.
British Journal of Clinical Pharmacology|July 1, 1989
The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoinR G Dickinson, W D Hooper, B Wood, et al.
Journal of the Autonomic Nervous System|December 1, 1994
The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in ratsG Eisenhofer, W Pecorella, K Pacak, et al.
Clinical Pharmacology and Therapeutics|September 1, 1973
The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoinF Bochner, W D Hooper, J M Sutherland, et al.
ANZ Journal of Surgery|January 24, 2023
Malignant polyps in the COVID-19 era: a population-based analysisAndrew P Zammit, Ian Brown, John D Hooper, et al.
Therapeutic Drug Monitoring|January 1, 1985
Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studiesW D Hooper, A R King, M Patterson, et al.
Annals of Coloproctology|March 25, 2024
Estimation of risk posed by malignant polyps amongst colorectal surgeons in Australia and New ZealandAndrew P Zammit, Ian Brown, John D Hooper, et al.
Pageof 47